No connection

Search Results

ENSG vs FMS

ENSG
The Ensign Group, Inc.
NEUTRAL
Price
$189.94
Market Cap
$11.1B
Sector
Healthcare
AI Confidence
85%
FMS
Fresenius Medical Care AG
BULLISH
Price
$22.77
Market Cap
$12.44B
Sector
Healthcare
AI Confidence
75%

Valuation

P/E Ratio
ENSG
32.47
FMS
11.56
Forward P/E
ENSG
23.05
FMS
5.62
P/B Ratio
ENSG
4.91
FMS
0.81
P/S Ratio
ENSG
2.19
FMS
0.63
EV/EBITDA
ENSG
23.82
FMS
6.25

Profitability

Gross Margin
ENSG
16.34%
FMS
25.62%
Operating Margin
ENSG
9.1%
FMS
11.68%
Profit Margin
ENSG
6.8%
FMS
4.98%
ROE
ENSG
16.89%
FMS
7.93%
ROA
ENSG
5.25%
FMS
3.62%

Growth

Revenue Growth
ENSG
20.2%
FMS
-0.3%
Earnings Growth
ENSG
18.4%
FMS
420.0%

Financial Health

Debt/Equity
ENSG
0.99
FMS
0.76
Current Ratio
ENSG
1.42
FMS
1.26
Quick Ratio
ENSG
1.35
FMS
0.85

Dividends

Dividend Yield
ENSG
0.14%
FMS
3.58%
Payout Ratio
ENSG
4.32%
FMS
42.76%

AI Verdict

ENSG NEUTRAL

ENSG presents a stable financial profile with a Piotroski F-Score of 5/9, indicating consistent but not exceptional operational health. While the stock trades at a significant premium to its Graham Number ($71.38), this is justified by robust 20.2% YoY revenue growth and a stellar 25-quarter earnings track record. However, the current price of $189.94 has exceeded the growth-based intrinsic value of $172.57, and bearish insider activity combined with a 0/100 technical trend suggests a period of consolidation or correction may be imminent.

Strengths
Exceptional earnings consistency with beats in 3 of the last 4 quarters and a long-term track record of 25 quarters
Strong top-line growth with YoY revenue increasing by 20.20%
Healthy profitability metrics including an ROE of 16.89% and operating margin of 9.10%
Risks
Current market price is trading above the calculated intrinsic value ($172.57)
Bearish insider sentiment with 6 sell transactions and 0 buys in the last 6 months
Technical trend is currently 0/100, indicating strong bearish momentum in the short term
FMS BULLISH

FMS presents a classic deep-value opportunity, characterized by a stable Piotroski F-Score of 6/9 and a current price ($22.77) trading significantly below both its Graham Number ($35.27) and Intrinsic Value ($58.12). While top-line revenue growth is stagnant (-0.30%), the company has demonstrated a massive recovery in earnings and maintains a sustainable dividend payout ratio of 42.76%. The valuation is exceptionally attractive with a Forward P/E of 5.62 and a Price/Book of 0.81. However, the bullish value thesis is countered by a completely bearish technical trend and weak insider sentiment, suggesting a 'value trap' risk if revenue does not stabilize.

Strengths
Significant undervaluation relative to Graham Number and Intrinsic Value
Strong earnings recovery with YoY growth of 420%
Attractive valuation multiples (P/B 0.81, P/S 0.63, Forward P/E 5.62)
Risks
Stagnant revenue growth (-0.30% YoY) indicating a lack of top-line momentum
Severe bearish technical trend (0/100 score)
Low insider sentiment (40/100) suggesting lack of internal confidence

Compare Another Pair

ENSG vs FMS: Head-to-Head Comparison

This page compares The Ensign Group, Inc. (ENSG) and Fresenius Medical Care AG (FMS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile